Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost/Timolol vs Latanoprost in Exfoliation Syndrome/Glaucoma
NCT01448837Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Apr 2010
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost, timolol in exfoliation syndrome (XFS), pseudoexfoliative glaucoma (PEXG), sponsored by Aristotle University of Thessaloniki. Started Apr 2010; status: completed.
02
Drugs
bimatoprosttimolol
03
Conditions
exfoliation syndrome (XFS)pseudoexfoliative glaucoma (PEXG)
Beyond the preview
Go deeper on NCT01448837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448837.